BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33389895)

  • 1. Bioengineered Exosomal Extracellular Vesicles in Cancer Therapeutics.
    Miles J; Andre M; Caobi A; Ruiz M; Nair M; Raymond AD
    Crit Rev Biomed Eng; 2020; 48(3):177-187. PubMed ID: 33389895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance.
    Vasconcelos MH; Caires HR; Ābols A; Xavier CPR; Linē A
    Drug Resist Updat; 2019 Dec; 47():100647. PubMed ID: 31704541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
    Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
    Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
    Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
    Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis.
    Hanjani NA; Esmaelizad N; Zanganeh S; Gharavi AT; Heidarizadeh P; Radfar M; Omidi F; MacLoughlin R; Doroudian M
    Crit Rev Oncol Hematol; 2022 Jan; 169():103565. PubMed ID: 34871719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.
    Soekmadji C; Corcoran NM; Oleinikova I; Jovanovic L; ; Ramm GA; Nelson CC; Jenster G; Russell PJ
    Prostate; 2017 Oct; 77(14):1416-1423. PubMed ID: 28856701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
    Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
    Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct detection of two different tumor-derived extracellular vesicles by SAM-AuNIs LSPR biosensor.
    Thakur A; Qiu G; Ng SP; Guan J; Yue J; Lee Y; Wu CL
    Biosens Bioelectron; 2017 Aug; 94():400-407. PubMed ID: 28324860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms.
    Li G; Tang W; Yang F
    Biotechnol J; 2020 May; 15(5):e1900225. PubMed ID: 32032977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy.
    Hu C; Jiang W; Lv M; Fan S; Lu Y; Wu Q; Pi J
    Front Immunol; 2022; 13():792046. PubMed ID: 35757760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles.
    Tatischeff I
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
    Srivastava A; Rathore S; Munshi A; Ramesh R
    AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M; Sharifi M
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-based liquid biopsies in cancer: opportunities and challenges.
    Yu W; Hurley J; Roberts D; Chakrabortty SK; Enderle D; Noerholm M; Breakefield XO; Skog JK
    Ann Oncol; 2021 Apr; 32(4):466-477. PubMed ID: 33548389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside.
    Wu K; Xing F; Wu SY; Watabe K
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):538-563. PubMed ID: 29054476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy.
    Mukherjee A; Bisht B; Dutta S; Paul MK
    Acta Pharmacol Sin; 2022 Nov; 43(11):2759-2776. PubMed ID: 35379933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology.
    Yokoi A; Ochiya T
    Semin Cancer Biol; 2021 Sep; 74():79-91. PubMed ID: 33798721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
    Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
    Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.